Condition category
Neonatal Diseases
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status

Plain English Summary

Background and study aims
Hypothermia occurs when body temperature drops below 35C (95F). One of the most effective ways to prevent hypothermia in newborn infants of extremely low birth weight is to immediately place them in a polyethylene bag, covering the trunk and limbs, covering the head with a wool cap or the bag itself. The polyethylene bags used are usually sterile bags used for packaging or organs or for preserving food, which were not originally designed for protection of the newborn. They are unadjusted for newborn containment, in particular of the head, where significant heat loss occurs. A polythene bag specifically designed for this purpose has recently been marketed, which fits easily on the body surface of the newborn, in particular the head. The aim of this study is to compare the effectiveness of two polyethylene bags for the prevention of hypothermia after birth in infants with gestational age ≤28 weeks.

Who can participate?
Newborns with gestational age ≤28 weeks

What does the study involve?
Newborns are randomly allocated to be placed either in the new bag or the usual bags. The effectiveness of the two bags at preventing hypothermia is determined by measuring the skin temperature of the newborns on admission to the neonatal intensive-care unit (NICU).

What are the possible benefits and risks of participating?
We expect that there will be less heat loss (higher skin temperature) with the new bag compared with the usual bag, leading to higher survival rates and other better outcomes. We do not expect any possible risk, as it is currently accepted practice to put preterm babies in plastic bags (face excluded) as this has been proved to be better than no bag.

Where is the study run from?
Maternidade Dr. Alfredo Da Costa and Hospital Professor Doutor Fernando Fonseca and Hospital Professor Doutor Fernando Fonseca (Portugal)

When is the study starting and how long is it expected to run for?
March 2016 to August 2018

Who is funding the study?
Vygon (Portugal)

Who is the main contact?
Dr Eduardo Fernandes

Trial website

Contact information



Primary contact

Dr Eduardo Fernandes


Contact details

Maternidade Dr. Alfredo Da Costa
Rua Viriato
1069-089 Lisbon

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Prevention of hypothermia, in the immediate neonatal period, in infants with gestational age ≤28 weeks: a comparative study of the effectiveness of two models of polyethylene bags


Study hypothesis

The hypothesis of the study is that it will be possible to obtain a significantly higher skin temperature (study of superiority) in newborns with Neohelp TM bag (intervention group) compared to the usual, single wall, bags (control group).

Ethics approval

1. Ethics Committee of Centro Hospitalar de Lisboa Central, 13/01/2016, ref: 255/2015
2. Ethics Committee of Professor Fernando Fonseca Hospital, 26/11/2015

Study design

Interventional clinical multicenter randomized prospective controlled open-label study

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet


Prevention of hypothermia, in the immediate neonatal period, in infants with gestational age ≤28 weeks


Informed consent will be obtained from one of the parents before birth. 
Randomization (1: 1) of newborns, for one of the two groups, will be performed immediately before delivery, through closed opaque envelope opening, numbered sequentially, which contains the assigned study group (intervention or control), obtained by table of random numbers generated by computer (variable block randomization for 2 to 4). Concealment of the intervention is not possible.

Newborn twins will be randomized individually. After childbirth and verifying the absence of exclusion criteria, the only difference in care between the two groups is the intervention: newborns randomized to the intervention group are placed immediately, without drying, in Neohelp TM bag and the newborns randomized to the control group are placed immediately, without drying, in the usual bags, with drying and head cover with a cap. The remaining practices, stabilization/resuscitation, transport to the Neonatal Intensive Care Unit (NICU) and routine care are determined by the usual practice of the units and will be the same in the two groups. After admission to the NICU, removing the polyethylene bag is held after the placement of central pathways and stabilization of body temperature (36.5-37,5ºC) in the incubator with 85% humidity.

The following variables will be recorded and monitored:
1. Delivery room ambient temperature (°C), immediately before the birth, with environmental pattern thermometer
2. Maternal temperature at delivery (°C)
3. Date and time of birth (hh:mm)
4. Time (hh:mm) and skin temperature (°C) of newborn in admission on the NICU, using skin temperature sensor, placed in the liver area
5. Newborn’s temperature (° C) 1 hour after admission
6. Gestational age (weeks and days)
7. Birth weight (grams)
8. Sex
9. Twinning and birth order
10. Type of delivery (cesarean section or vaginal)
11. Maternal fever (> 37.5 ° C)
12. Chorioamnionitis
13. Tracheal intubation at birth
14. Need of advanced resuscitation at birth (cardiac massage, adrenaline, umbilical catheterization)
15. Worst pH and base deficit in the first 6 hours
16. Maximum O2 needed in the first 24 hours
17. Number of days of O2 supplement
18. Number of days of invasive ventilation
19. Number of days of non-invasive ventilation
20. Hypoglycemia during the first 24 hours of life (<45 mg/dl)
21. Hypotension in the first 24 hours of life (TAM <IG in weeks)
22. Patent ductus arteriosus with hemodynamic repercussion
23. Necrotizing enterocolitis (modified Bell’s criteria)
24. Isolated gastrointestinal perforation
25. Hyaline membrane disease
26. Pulmonary hemorrhage
27. Pneumothorax
28. Bronchopulmonary dysplasia (need for supplemental O2 at 36 weeks of corrected age, in association with radiological characteristics changes)
29. Intraventricular hemorrhage (grade according to Volpe classification)
30. Cystic periventricular leukomalacia (De Vries classification)
31. Retinopathy of prematurity (grade according to International Classification of retinopathy of prematurity)
32. Late sepsis (with isolation in blood culture)
33. Hospital stay
34. Mortality during hospitalization
35. Cause of death (congenital anomaly, extreme prematurity, infectious, neurological, cardiopulmonary, gastrointestinal, other)

The duration of follow-up will be until hospital discharge.

Intervention type



Drug names

Primary outcome measures

The effectiveness of the two polyethylene bag models in the prevention of neonatal hypothermia immediately after birth by measuring skin temperature of newborns on admission to the NICU

Secondary outcome measures

Comparison of the two groups for the following secondary variables related with hypothermia:
1. Metabolic acidosis
2. Hypotension
3. Hypoglycemia
4. Patent ductus arteriosus with hemodynamic significance
5. Necrotizing enterocolitis
6. Isolated gastrointestinal perforation
7. Respiratory distress syndrome
8. Pulmonary hemorrhage
9. Pneumothorax
10. Bronchopulmonary dysplasia
11. Intraventricular hemorrhage
12. Periventricular leukomalacia
13. Retinopathy of prematurity
14. Sepsis
15. Hospital stay
16. Mortality
17. Causes of death
Secondary outcomes will be measured until date of hospital discharge.

Overall trial start date


Overall trial end date


Reason abandoned


Participant inclusion criteria

1. Newborn infants with gestational age between 24 weeks and 0/7 days and 28 weeks and 0/7 days, according to the best obstetric estimate
2. Born in Dr. Alfredo da Costa Maternity and Professor Dr. Fernando Fonseca Hospital
3. With informed consent

Participant type


Age group




Target number of participants

For detection of a difference in mean skin temperature of 1 ° C (36 ° C, SD 0.73) in the intervention group versus control group (study superiority unidirectional) with alpha 0.05 and a power of 0.8, we require 9 x 2 = 18 + 20% = 22 participants. For linear regression analysis, considering the adjustment to 1 or 2 covariates, we require about 72 to 80 cases (40 in each study group).

Participant exclusion criteria

1. Newborns with congenital anomalies not covered by skin (gastroschisis, myelominingocele) or with skin lesions that prevent the skin covering with polyethylene bag
2. Deceased in the delivery room

Recruitment start date


Recruitment end date



Countries of recruitment


Trial participating centre

Maternidade Dr. Alfredo Da Costa
Rua Viriato
1069-089 Lisbon

Trial participating centre

Hospital Professor Doutor Fernando Fonseca
Hospital Prof. Doutor Fernando Fonseca E.P.E . IC 19, 2720-276 Amadora
2720-276 Amadora

Sponsor information


Vygon (Portugal)

Sponsor details

Parque Empresarial de Baltar/Parada
Rua F – Lote 1
4585-013 BALTAR

Sponsor type




Funder type


Funder name

Vygon (Portugal)

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

We intend to publish the results of the trial some months (6?) after it is finished in a large impact publication. We intend to make the data freely available, after anonymization, to other scientists, namely for meta-analysis or reviews.

Intention to publish date


Participant level data

To be made available at a later date

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes